Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 2/20 | 0.63 |
| ▸ | CES1 | P23141 | 1/20 | 0.57 |
| ▸ | MIF | P14174 | 9/20 | 0.56 |
| ▸ | PKM | P14618 | 3/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.53 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.51 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.51 |
| ▸ | RELA | Q04206 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8872382 | 1.00 | MAOB (0.63) | MAOBCES1MIFPKMCYP19A1 | |
| SCHEMBL20359030 | 1.00 | MAOB (0.63) | MAOBCES1MIFPKMCYP19A1 | |
| SCHEMBL8872375 | 1.00 | MAOB (0.63) | MAOBCES1MIFPKMCYP19A1 | |
| SCHEMBL3697186 | 0.87 | MAOB (0.50) | MAOBCES1MIFCYP19A1CYP11B2 | |
| SCHEMBL9179498 | 0.87 | MAOB (0.50) | MAOBCES1MIFCYP19A1CYP11B2 | |
| SCHEMBL3697185 | 0.87 | MAOB (0.50) | MAOBCES1MIFCYP19A1CYP11B2 | |
| SCHEMBL979339 | 0.85 | MAOB (0.58) | MAOBCES1MIFPKMCYP19A1 | |
| SCHEMBL2247150 | 0.84 | MIF (0.62) | MAOBCES1MIFCYP19A1MAPT | |
| SCHEMBL9431705 | 0.84 | MIF (0.62) | MAOBCES1MIFCYP19A1MAPT | |
| SCHEMBL2247155 | 0.84 | MIF (0.62) | MAOBCES1MIFCYP19A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260085073-A1 | PYRAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY | HOTSPOT THERAPEUTICS INC (US) | 2026-03-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260085073-A1 | PYRAZOLYLCARBOXAMIDE COMPOUNDS AND THEIR USE IN THERAPY | MALT1, BCL6, BCL3 | MAOB 4757/4885CES1 703/4885MIF 905/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.